SOLS trades 51.9% below Wall Street's consensus target of $94.33.
Last 12 months price action with 12-month analyst target path
The base valuation assumes SOLS achieves its forward estimates and maintains a stable P/E multiple of 23.3x. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Solstice Advanced Materials Inc. (SOLS) has a Wall Street consensus price target of $94.33, based on estimates from 4 covering analysts. With the stock currently trading at $62.10, this represents a potential upside of +51.9%. The company has a market capitalization of $9.86B.
Analyst price targets range from a low of $88.00 to a high of $102.00, representing a 15% spread in expectations. The median target of $92.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, SOLS trades at a trailing P/E of 41.7x and forward P/E of 23.3x. Analysts expect EPS to grow +105.4% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $60.17, with bear and bull scenarios of $37.91 and $79.28 respectively. Model confidence stands at 50/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
MTRNMaterion Corporation | $5.1B | $247.20 | $161.00 | -34.9% | Buy | 38.5x | 10 |
KALUKaiser Aluminum Corporation | $2.8B | $170.83 | $165.33 | -3.2% | Hold | 16.6x | 22 |
HWKNHawkins, Inc. | $2.8B | $136.26 | $170.00 | +24.8% | Buy | 34.6x | 1 |
ASIXAdvanSix Inc. | $565M | $20.97 | $22.00 | +4.9% | Buy | 14.6x | 6 |
EMNEastman Chemical Company | $8.0B | $69.62 | $79.44 | +14.1% | Buy | 10.9x | 35 |
HUNHuntsman Corporation | $1.9B | $10.97 | $13.60 | +24.0% | Hold | — | 33 |
TROXTronox Holdings plc | $976M | $6.12 | $8.33 | +36.1% | Buy | — | 17 |
KROKronos Worldwide, Inc. | $687M | $5.97 | $7.50 | +25.6% | Hold | — | 7 |
IOSPInnospec Inc. | $2.0B | $81.66 | $115.00 | +40.8% | Hold | 17.1x | 9 |
APDAir Products and Chemicals, Inc. | $67.9B | $305.05 | $329.25 | +7.9% | Buy | 23.1x | 42 |
Quick answers to the most common questions about buying SOLS stock.
The consensus Wall Street price target for SOLS is $94.33, representing 51.9% upside from the current price of $62.1. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
SOLS has a consensus rating of "Buy" based on 4 Wall Street analysts. The rating breakdown is mixed, with 2 Hold ratings making up the largest segment. The consensus 12-month price target of $94.33 implies 51.9% upside from current levels.
SOLS trades at a forward P/E of 23.3248x, representing a moderate valuation. With analysts targeting $94.33 (51.9% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $102 for SOLS, while the most conservative target is $88. The consensus of $94.33 represents the median expectation. Our quantitative valuation model projects a bull case target of $79 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
SOLS is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month SOLS stock forecast based on 4 Wall Street analysts shows a consensus price target of $94.33, with estimates ranging from $88 (bear case) to $102 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $60, with bear/bull scenarios of $38/$79.
Our quantitative valuation model calculates SOLS's fair value at $60 (base case), with a bear case of $38 and bull case of $79. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 50/100.
SOLS trades at a forward P/E ratio of 23.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 41.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on SOLS, with a "Buy" consensus rating and $94.33 price target (51.9% upside). 2 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
SOLS analyst price targets range from $88 to $102, a 15% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $94.33 consensus represents the middle ground. Our model's $38-$79 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.